CIBC Asset Management Inc raised its stake in Veeva Systems Inc. (NYSE:VEEV – Free Report) by 5.5% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,641 shares of the technology company’s stock after acquiring an additional 294 shares during the quarter. CIBC Asset Management Inc’s holdings in Veeva Systems were worth $1,184,000 at the end of the most recent reporting period.
Several other hedge funds have also recently bought and sold shares of the stock. OneDigital Investment Advisors LLC grew its stake in shares of Veeva Systems by 7.3% in the third quarter. OneDigital Investment Advisors LLC now owns 1,909 shares of the technology company’s stock valued at $401,000 after acquiring an additional 130 shares in the last quarter. Tokio Marine Asset Management Co. Ltd. grew its position in shares of Veeva Systems by 1.2% during the 3rd quarter. Tokio Marine Asset Management Co. Ltd. now owns 4,307 shares of the technology company’s stock worth $904,000 after purchasing an additional 50 shares in the last quarter. Metis Global Partners LLC increased its holdings in shares of Veeva Systems by 13.1% during the third quarter. Metis Global Partners LLC now owns 5,057 shares of the technology company’s stock worth $1,061,000 after purchasing an additional 584 shares during the period. Snider Financial Group raised its position in shares of Veeva Systems by 1.1% in the third quarter. Snider Financial Group now owns 14,769 shares of the technology company’s stock valued at $3,100,000 after buying an additional 160 shares in the last quarter. Finally, Huntington National Bank raised its position in shares of Veeva Systems by 19.8% in the third quarter. Huntington National Bank now owns 1,559 shares of the technology company’s stock valued at $327,000 after buying an additional 258 shares in the last quarter. 88.20% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling at Veeva Systems
In other Veeva Systems news, insider Thomas D. Schwenger sold 1,126 shares of the stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $240.01, for a total transaction of $270,251.26. Following the completion of the sale, the insider now directly owns 27,013 shares in the company, valued at approximately $6,483,390.13. This trade represents a 4.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 10.50% of the company’s stock.
Analyst Upgrades and Downgrades
Check Out Our Latest Stock Analysis on VEEV
Veeva Systems Stock Performance
Shares of NYSE:VEEV opened at $210.63 on Thursday. Veeva Systems Inc. has a 52 week low of $165.12 and a 52 week high of $240.68. The firm has a market cap of $34.11 billion, a PE ratio of 56.17, a price-to-earnings-growth ratio of 2.06 and a beta of 0.81. The firm’s fifty day moving average is $214.68 and its 200-day moving average is $201.00.
Veeva Systems (NYSE:VEEV – Get Free Report) last announced its earnings results on Wednesday, August 28th. The technology company reported $1.07 EPS for the quarter, topping the consensus estimate of $1.04 by $0.03. The firm had revenue of $676.18 million for the quarter, compared to the consensus estimate of $667.21 million. Veeva Systems had a return on equity of 13.30% and a net margin of 23.91%. Sell-side analysts forecast that Veeva Systems Inc. will post 4.21 EPS for the current year.
Veeva Systems Company Profile
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Further Reading
- Five stocks we like better than Veeva Systems
- Using the MarketBeat Dividend Tax Calculator
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- Why Are These Companies Considered Blue Chips?
- Williams-Sonoma Stock: Buy It and Never Let It Go
- Are Penny Stocks a Good Fit for Your Portfolio?
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.